1. Home
  2. MDAIW vs SATS Comparison

MDAIW vs SATS Comparison

Compare MDAIW & SATS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDAIW
  • SATS
  • Stock Information
  • Founded
  • MDAIW N/A
  • SATS 2007
  • Country
  • MDAIW United States
  • SATS United States
  • Employees
  • MDAIW 78
  • SATS N/A
  • Industry
  • MDAIW Medical/Dental Instruments
  • SATS Telecommunications Equipment
  • Sector
  • MDAIW Health Care
  • SATS Consumer Discretionary
  • Exchange
  • MDAIW Nasdaq
  • SATS Nasdaq
  • Market Cap
  • MDAIW N/A
  • SATS N/A
  • IPO Year
  • MDAIW N/A
  • SATS 2007
  • Fundamental
  • Price
  • MDAIW $0.37
  • SATS $17.73
  • Analyst Decision
  • MDAIW
  • SATS Hold
  • Analyst Count
  • MDAIW 0
  • SATS 5
  • Target Price
  • MDAIW N/A
  • SATS $22.50
  • AVG Volume (30 Days)
  • MDAIW 35.6K
  • SATS 3.6M
  • Earning Date
  • MDAIW 02-27-2025
  • SATS 05-09-2025
  • Dividend Yield
  • MDAIW N/A
  • SATS N/A
  • EPS Growth
  • MDAIW N/A
  • SATS N/A
  • EPS
  • MDAIW N/A
  • SATS N/A
  • Revenue
  • MDAIW $27,264,000.00
  • SATS $15,680,431,000.00
  • Revenue This Year
  • MDAIW N/A
  • SATS N/A
  • Revenue Next Year
  • MDAIW N/A
  • SATS N/A
  • P/E Ratio
  • MDAIW N/A
  • SATS N/A
  • Revenue Growth
  • MDAIW 44.52
  • SATS N/A
  • 52 Week Low
  • MDAIW $0.08
  • SATS $14.79
  • 52 Week High
  • MDAIW $0.90
  • SATS $32.48
  • Technical
  • Relative Strength Index (RSI)
  • MDAIW N/A
  • SATS 31.50
  • Support Level
  • MDAIW N/A
  • SATS $19.56
  • Resistance Level
  • MDAIW N/A
  • SATS $23.73
  • Average True Range (ATR)
  • MDAIW 0.00
  • SATS 1.62
  • MACD
  • MDAIW 0.00
  • SATS -0.33
  • Stochastic Oscillator
  • MDAIW 0.00
  • SATS 2.73

About MDAIW Spectral AI Inc.

Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient's wound.

Share on Social Networks: